On February 24, the private members Bill C-213, An Act to enact the Canada Pharmacare Act, was defeated. This Bill, tabled last February 2020 by NDP MP, Peter Julian, had the support of all members of the NDP and Green Party, one Conservative, two Liberal & two independents MPs.

The Government has announced the implementation of the amended Patented Medicines Regulations will be delayed once again until July 1, 2021.

Two new appointments for The Pangaea Group effective January 1, 2021.

Health Canada (HC) has issued an Interim Order (IO) to safeguard Canada’s drug supply from diversion.

The final PMPRB Guidelines have been published along with an "Overview of Final Changes" that differ from the June 2020 draft Guidelines.

On September 16, 2020, the Feds issued an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 that allows for the Minister of Health to expedite review of COVID-19 drugs in Canada. There are three routes.

Sometimes the new normal is simply dealing with a new level of systematic complexity that arises as the health economy and population grows, and we grapple with an ever-expanding landscape of health system needs that are as complex as they are diverse.

On July 8, the PMPRB updated its website to include its views on the recent Federal Court decision pertaining to the amendments to the Patented Medicines Regulations and their impact on the Guidelines.

Join our team: Pangaea is seeking a part-time / independent consultant to support our trade team as a Trade Manager.

Overall, there are 14 projects under the R2D2 initiative that can be bucketed into four categories. Read more.